Rezultati pretraživanja
  1. prije 7 sati

    ICYMI: The FDA has approved the first drug therapy for

  2. prije 9 sati

    U.S. Food and Drug Administration Approves First Treatment For Children With Peanut Allergies

  3. Congratulations Aimmune Therapeutics on the FDA approval of PALFORZIA. PALFORZIA is the first and only FDA-approved oral immunotherapy for peanut allergies that can help reduce the severity of allergic reactions.

  4. 5. velj

    First ever drug approved to treat peanut allergies

  5. 4. velj
  6. 4. velj

    We also greatly appreciate the critical work by all RAMSES physician investigators and their staff – thank you for your support

    Prikaži ovu nit
  7. 4. velj

    Thank you to all of the PALISADE physician investigators and their staff who worked tirelessly to help get us to this approval

    Prikaži ovu nit
  8. 4. velj
  9. 3. velj
    Odgovor korisniku/ci

    That's a baby murderer to me . I was triggered!

  10. 3. velj

    New treatment for sufferers. allergy drug approved by the US

  11. 3. velj
    Odgovor korisniku/ci

    Stay away from me

  12. 3. velj

    Omg there is a new Mr. Peanut. I’m gonna die.

  13. 2. velj

    approves first drug for treatment of peanut allergy for children

  14. 2. velj
  15. 1. velj
  16. 1. velj

    An amazing milestone for people with ! A tremendous thanks to the pioneer study participants and families who gave so much to make this happen. Proud of faculty and staff at for contributing.

  17. 1. velj
  18. 31. sij

    Speaking solely as mom of a kid w/ , I’m grateful for the & thank all who joined & ran these . That said, a product that still requires allergen avoidance, 100% avail of epi, & can itself cause anaphylaxis is a 👎🏼 for me as a mom. 😞

    Prikaži ovu nit
  19. 31. sij

    BREAKING NEWS: We’re proud to announce FDA approval of the first treatment for . Read our release and the full Prescribing Information, including Boxed WARNING, and Medication Guide:

    Prikaži ovu nit

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.